Counterfeiting of medicinal products

This procedure focuses on strengthening measures to prevent the entry of counterfeit medicines into the legal supply chain. By improving tracking and security, the initiative aims to protect public health and ensure that patients receive safe, authentic medications.

This affects pharmaceutical manufacturers, distributors, and healthcare providers. It introduces stricter controls and monitoring requirements to identify and remove fake drugs from the market.